Evidence map›Paper›PMID 27547025›Full record

Trial reportJSLS : Journal of the Society of Laparoendoscopic Surgeons

Transanal Minimally Invasive Surgery for Rectal Lesions.

Silvia Quaresima, Andrea Balla, Luana Franceschilli, Marco La Torre, Corrado Iafrate, Mostafa Shalaby, Nicola Di Lorenzo, Pierpaolo Sileri

Open access · hybridAbstract readClinical Trial
In one paragraph

Trial report in JSLS : Journal of the Society of Laparoendoscopic Surgeons. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
2.7field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 44 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Is there any role for minimally invasive surgery in NET?Reviews in endocrine & metabolic disorders · 2017
    Review
  14. Review
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Silvia QuaresimaDepartment of General Surgery; University of Rome "Tor Vergata," Rome, Italy.
Andrea BallaDepartment of General Surgery; University of Rome "Tor Vergata," Rome, Italy.
Luana FranceschilliDepartment of General Surgery; University of Rome "Tor Vergata," Rome, Italy.
Marco La TorreDepartment of General Surgery; University of Rome "Tor Vergata," Rome, Italy.
Corrado IafrateDepartment of General Surgery; University of Rome "Tor Vergata," Rome, Italy.
Mostafa ShalabyDepartment of General Surgery; University of Rome "Tor Vergata," Rome, Italy.
Nicola Di LorenzoDepartment of General Surgery; University of Rome "Tor Vergata," Rome, Italy.
Pierpaolo SileriDepartment of General Surgery; University of Rome "Tor Vergata," Rome, Italy.
University of Rome Tor Vergata · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND AND

objectivesTransanal minimally invasive surgery (TAMIS) has emerged as an alternative to transanal endoscopic microsurgery (TEM). The authors report their experience with TAMIS for the treatment of mid and high rectal tumors.

methodsFrom November 2011 through May 2016, 31 patients (21 females, 68%), with a median age of 65 years who underwent single-port TAMIS were prospectively enrolled. Mean distance from the anal verge of the rectal tumors was 9.5 cm. Seventeen patients presented with T1 cancer, 10 with large adenoma, 2 with gastrointestinal stromal tumor (GIST) and 2 with carcinoid tumor. Data concerning demographics, operative procedure and pathologic results were analyzed.

resultsTAMIS was successfully completed in all cases. In 4 (13%) TAMIS was converted to standard Park's transanal technique. Median postoperative stay was 3 days. The overall complication rate was 9.6%, including 1 urinary tract infection, 1 subcutaneous emphysema, and 1 hemorrhoidal thrombosis. TAMIS allowed an R0 resection in 96.8% of cases (30/31 cases) and a single case of local recurrence after a large adenoma resection was encountered.

conclusionTAMIS is a safe technique, with a short learning curve for laparoscopic surgeons already proficient in single-port procedures, and provides effective oncological outcomes compared to other techniques.

Indexed as

AdenomaAdultAgedAged, 80 and overCarcinoid TumorFemaleFollow-Up StudiesGastrointestinal Stromal TumorsHumansLaparoscopyMaleMiddle AgedProspective StudiesRectal NeoplasmsTransanal Endoscopic SurgeryTreatment OutcomeColorectal surgeryNatural orifice transluminal endoscopic surgery (NOTES) Single-site laparoscopic surgery (SILS)Surgical oncologyTransanal minimally invasive Surgery (TAMIS)

Identifiers

PMID27547025
PMCPMC4978546
OpenAlexW2515775495

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.